Literature DB >> 15569798

Construction of yellow fever/St. Louis encephalitis chimeric virus and the use of chimeras as a diagnostic tool.

Konstantin V Pugachev1, Farshad Guirakhoo, Fred Mitchell, Simeon W Ocran, Megan Parsons, Barbara W Johnson, Olga L Kosoy, Robert S Lanciotti, John T Roehrig, Dennis W Trent, Thomas P Monath.   

Abstract

St. Louis encephalitis (SLE) and West Nile (WN) flaviviruses are genetically closely related and cocirculate in the United States. Virus neutralization tests provide the most specific means for serodiagnosis of infections with these viruses. However, use of wild-type SLE and WN viral strains for laboratory testing is constrained by the biocontainment requirements. We constructed two highly attenuated yellow fever (YF) virus chimeras that contain the premembrane-envelope (prM-E) protein genes from the virulent MSI-7 (isolated in the United States) or the naturally attenuated CorAn9124 (Argentina) SLE strains. The YF/SLE (CorAn version) virus and the previously constructed YF/WN chimera were shown to specifically distinguish between confirmed human SLE and WN cases in a virus neutralization test using patient sera. These chimeras have the potential for use as diagnostic reagents and vaccines against SLE and WN.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15569798

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  13 in total

1.  Sequential immunization with heterologous chimeric flaviviruses induces broad-spectrum cross-reactive CD8+ T cell responses.

Authors:  Rekha Singh; Alan L Rothman; James Potts; Farshad Guirakhoo; Francis A Ennis; Sharone Green
Journal:  J Infect Dis       Date:  2010-07-15       Impact factor: 5.226

2.  Evaluation of three commercially available Japanese encephalitis virus IgM enzyme-linked immunosorbent assays.

Authors:  Jaimie S Robinson; David Featherstone; Ravi Vasanthapuram; Brad J Biggerstaff; Anita Desai; Nalini Ramamurty; Anwarul Haque Chowdhury; Hardeep S Sandhu; Kathleen F Cavallaro; Barbara W Johnson
Journal:  Am J Trop Med Hyg       Date:  2010-11       Impact factor: 2.345

3.  Use of a surrogate chimeric virus to detect West Nile virus-neutralizing antibodies in avian and equine sera.

Authors:  Nicholas Komar; Stanley Langevin; Thomas P Monath
Journal:  Clin Vaccine Immunol       Date:  2008-11-12

4.  Recovery of West Nile Virus Envelope Protein Domain III Chimeras with Altered Antigenicity and Mouse Virulence.

Authors:  Alexander J McAuley; Maricela Torres; Jessica A Plante; Claire Y-H Huang; Dennis A Bente; David W C Beasley
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

5.  Evaluation of St. Louis encephalitis virus/dengue virus type 4 antigenic chimeric viruses in mice and rhesus monkeys.

Authors:  Joseph E Blaney; James Speicher; Christopher T Hanson; Neeraj S Sathe; Stephen S Whitehead; Brian R Murphy; Alexander G Pletnev
Journal:  Vaccine       Date:  2008-06-13       Impact factor: 3.641

6.  Evaluation of chimeric Japanese encephalitis and dengue viruses for use in diagnostic plaque reduction neutralization tests.

Authors:  Barbara W Johnson; Olga Kosoy; Elizabeth Hunsperger; Manuela Beltran; Mark Delorey; Farshad Guirakhoo; Thomas Monath
Journal:  Clin Vaccine Immunol       Date:  2009-05-20

Review 7.  Flaviviruses, an expanding threat in public health: focus on dengue, West Nile, and Japanese encephalitis virus.

Authors:  Carlo Amorin Daep; Jorge L Muñoz-Jordán; Eliseo Alberto Eugenin
Journal:  J Neurovirol       Date:  2014-10-07       Impact factor: 2.643

8.  Substitution of wild-type yellow fever Asibi sequences for 17D vaccine sequences in ChimeriVax-dengue 4 does not enhance infection of Aedes aegypti mosquitoes.

Authors:  Charles E McGee; Konstantin Tsetsarkin; Dana L Vanlandingham; Kate L McElroy; Jean Lang; Bruno Guy; Thierry Decelle; Stephen Higgs
Journal:  J Infect Dis       Date:  2008-03-01       Impact factor: 5.226

Review 9.  Preclinical and clinical development of a YFV 17 D-based chimeric vaccine against West Nile virus.

Authors:  Gustavo H Dayan; Konstantin Pugachev; Joan Bevilacqua; Jean Lang; Thomas P Monath
Journal:  Viruses       Date:  2013-12-09       Impact factor: 5.048

10.  Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity.

Authors:  Troy Querec; Soumaya Bennouna; Sefik Alkan; Yasmina Laouar; Keith Gorden; Richard Flavell; Shizuo Akira; Rafi Ahmed; Bali Pulendran
Journal:  J Exp Med       Date:  2006-02-06       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.